Compare DMCC Speciality with Similar Stocks
Dashboard
Company has a low Debt to Equity ratio (avg) at 0.31 times
Poor long term growth as Operating profit has grown by an annual rate 15.38% of over the last 5 years
The company has declared Positive results for the last 6 consecutive quarters
With ROCE of 17.4, it has a Very Attractive valuation with a 2.3 Enterprise value to Capital Employed
Despite the size of the company, domestic mutual funds hold only 0.02% of the company
Stock DNA
Specialty Chemicals
INR 588 Cr (Micro Cap)
22.00
NA
1.07%
0.16
11.89%
2.49
Total Returns (Price + Dividend) 
Latest dividend: 2.5 per share ex-dividend date: Aug-22-2025
Risk Adjusted Returns v/s 
Returns Beta
News

DMCC Speciality Chemicals Ltd Upgraded to Hold on Technical and Valuation Improvements
DMCC Speciality Chemicals Ltd has seen its investment rating upgraded from Sell to Hold as of 10 March 2026, reflecting a nuanced improvement across technical indicators, valuation metrics, financial trends, and quality assessments. This shift comes amid a backdrop of mixed long-term returns but encouraging recent financial performance and technical signals, prompting a reassessment of the stock’s outlook within the Specialty Chemicals sector.
Read full news article
DMCC Speciality Chemicals Ltd Sees Technical Momentum Shift Amid Mixed Market Signals
DMCC Speciality Chemicals Ltd has experienced a notable shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook, reflecting a complex interplay of technical indicators. Despite a 3.89% gain in the latest session, the stock’s mixed signals across weekly and monthly charts suggest cautious optimism for investors navigating the specialty chemicals sector.
Read full news article
DMCC Speciality Chemicals Ltd is Rated Sell
DMCC Speciality Chemicals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 February 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 28 February 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article Announcements 
Corporate Actions 
No Upcoming Board Meetings
DMCC Speciality Chemicals Ltd has declared 25% dividend, ex-date: 22 Aug 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 1 Schemes (0.01%)
Held by 3 FIIs (0.13%)
Laxmikumar Narottam Goculdas (36.27%)
Girish Gulati (huf) (2.28%)
33.27%
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
YoY Growth in quarter ended Dec 2025 is 27.81% vs 46.58% in Dec 2024
YoY Growth in quarter ended Dec 2025 is -21.60% vs 2,438.71% in Dec 2024
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 34.58% vs 16.00% in Sep 2024
Growth in half year ended Sep 2025 is 88.16% vs 30.31% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 31.97% vs 26.15% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 30.76% vs 158.59% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 31.51% vs -15.18% in Mar 2024
YoY Growth in year ended Mar 2025 is 85.76% vs 67.24% in Mar 2024






